Recent Quotes (30 days)

You have no recent quotes
chg | %

Life Science Developments Ltd news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

LIFE 3.19 +0.19 (6.50%)
price chart
Life Science Developments Looking To Buy After Leaving Copper Behind
The company was formerly Copper Development Corp but changed its investment policy and name in 2015. It sold off its copper interests in late 2015 and in early 2016, leaving it focused instead on identifying investment opportunities in the life ...
CompaniesGSK invests in UK sites in vote of confidence in Brexit Britain
GlaxoSmithKline, the largest UK drug company, is to invest an extra �275m at three British manufacturing sites, in a vote of confidence in the country following the Brexit referendum vote.
GlaxoSmithKline invests 275 million pounds in post-Brexit UK manufacturing  Reuters UK
GlaxoSmithKline invests $360 million in UK despite Brexit vote  Reuters
Why Britain and America are streets ahead of Europe in cutting-edge innovation
For example, US scientists have 45 per cent of all the citations in life sciences in academic journals, while we have just 15 per cent.
Labour proposes scrapping �1bn tax relief designed to promote innovation
The shadow chancellor said the so-called patent box, which boosts profits from patented innovations by halving the rate of corporation tax to 10%, was a “potential tax loophole with limited impact on research”. McDonnell said the benefit was enjoyed ...
Biology's Search for New Model Organisms
About Quanta. Quanta Magazine's mission is to enhance public understanding of research developments in mathematics and the physical and life sciences. Quanta articles do not necessarily represent the views of the Simons Foundation. Learn more.
OptiBiotix enters joint venture
OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, has completed a trial launch for its Slimbiome ingredients in a range of meal replacement shakes and snack bars, and invested ...
Life Sciences BPO Market Size to Reach $420 Billion by 2024: Grand View ...
The life sciences BPO market is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage ...
Nine in 10 Life Sciences Organizations Worry About Drug Pricing Pressures ...
“Amid market turbulence and a difficult IPO environment, the life sciences sector has also experienced a few bright spots in M&A activity as well as promising research and product developments,” said Ryan Starkes, Assurance Partner and Leader of the ...
UK firm buys Sardinian DNA samples for research into disease and ageing
Tiziana Life Sciences has bought a biobank containing DNA samples from 13,000 genealogically linked residents of Ogliastra for €258,000 (�217,000).
Tiziana takes plunge into the Sardinia gene pool  Proactive Investors UK
Life Extension-supported study published in Lancet Neurology finds green tea ...
"We are excited that the benefits observed in the early pilot and preclinical research extended to this larger trial," says Luke G. Huber, ND, MBA, vice president of product innovation and scientific development at Life Extension. "This new research ...